MPS Pharmaa (BOM:531686) EV-to-FCF: (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531686 MPS Pharmaa Ltd BOM:531686
11 GF Score
Price ₹1.99
! 3 Warning Signs
View Full Analysis

What is MPS Pharmaa EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, MPS Pharmaa's Enterprise Value is ₹113.26 Mil. MPS Pharmaa's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.00 Mil. Therefore, MPS Pharmaa's EV-to-FCF for today is .

The historical rank and industry rank for MPS Pharmaa's EV-to-FCF or its related term are showing as below:

BOM:531686' s EV-to-FCF Range Over the Past 10 Years
Min: -18.91   Med: 0   Max: 0
Current: -18.91

BOM:531686's EV-to-FCF is ranked worse than
100% of 564 companies
in the Drug Manufacturers industry
Industry Median: 21.825 vs BOM:531686: -18.91

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-11), MPS Pharmaa's stock price is ₹1.99. MPS Pharmaa's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-0.550. Therefore, MPS Pharmaa's PE Ratio (TTM) for today is At Loss.


MPS Pharmaa  (BOM:531686) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

MPS Pharmaa's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.99/-0.550
=At Loss

MPS Pharmaa's share price for today is ₹1.99.
MPS Pharmaa's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.550.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


MPS Pharmaa EV-to-FCF Related Terms


MPS Pharmaa EV-to-FCF Historical Data

* Premium members only.

The historical data trend for MPS Pharmaa's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MPS Pharmaa EV-to-FCF Chart

MPS Pharmaa Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.94 -10.96 -20.62 -23.58 -18.10

MPS Pharmaa Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.58 0.00 0.00 0.00 -18.10

BOM:531686 vs ZTS: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MPS Pharmaa's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MPS Pharmaa EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPS Pharmaa's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where MPS Pharmaa's EV-to-FCF falls into.


BOM:531686
11GF Score
MPS Pharmaa Ltd BOM:531686
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MPS Pharmaa EV-to-FCF Calculation

MPS Pharmaa's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=113.259/0
=

MPS Pharmaa's current Enterprise Value is ₹113.26 Mil.
MPS Pharmaa's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MPS Pharmaa Business Description

Address 19 Barakhamba Road, Connaught Place, 703, Arunachal Building, New Delhi, IND, 110001
MPS Pharmaa Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing, marketing, trading, and exporting Pharmaceutical Products. The company manufactures and exports medicines that include antihypertensive medicines, antihypertensive tablets, antifungal tablets, antifungal capsules, erectile dysfunction drugs, sedatives, corticosteroid medicines, antimalarials, anthelmintics, antipyretic & anti-inflammatory, and antibacterials & antibiotics. Its products include Wibatol, Robial, Twosum, Arfa Gel, and others.
11GF Score

Get the complete analysis for BOM:531686

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1.99
Price